Join the club for FREE to access the whole archive and other member benefits.

Hanadie Yousef

Co-founder and CEO of Juvena Therapeutics

Dr. Hanadie Yousef is a trained stem cell biologist,  neurobiologist, and chemical biologist with a focus on the mechanisms of aging, with multiple issued and pending patents and several publications on methods for tissue rejuvenation during the last 17 years conducting research in numerous prestigious institutions.

Dr. Yousef earned a BS in chemistry with a minor in Spanish from Carnegie Mellon University, a PhD in Molecular and Cell Biology from UC Berkeley, a 4.5-year postdoctoral fellowship at Stanford School of Medicine in Neurology, and has worked in R&D at  Regeneron and Genentech. In 2017, Dr. Yousef co-founded Juvena Therapeutics, Inc., to pursue her dream to build a revolutionary biopharmaceutical company that develops new medicines to promote tissue regeneration and increase healthspan in the elderly.

Visit website: https://www.juvenatherapeutics.com/hyousefbio

 hanadie-yousef-a2120026

 HanadieYousef

See also: Company Juvena Therapeutics - Biopharma discovering novel protein-based therapeutics that promote tissue regeneration

Details last updated 11-Feb-2020

Hanadie Yousef is also referenced in the following:

Age-Related Disease Therapeutics Summit

31-May-2023 to 02-Jun-2023

Event about aging and aging related diseases organized by Hanson Wade

Global Healthspan Summit 2023

29-Nov-2023 to 30-Nov-2023

Longevity summit organised by Hevolution Foundation (Riyadh,Saudi Arabia)

Metabesity 2021

11-Oct-2021 to 14-Oct-2021

The Kitalys institute virtual conference targeting key questions that will impact the future of aging and extending healthspan

Hanadie Yousef Blog Posts

Highlights of Ending Age-Related Diseases 2020
10-Sep-2020

Highlights of Ending Age-Related Diseases 2020

Key points from 20 presentations from world-leading researchers

Hanadie Yousef News

Reason reports back from Age-Related Disease Therapeutics Summit 2023

Fight Aging! - 16-Jun-2023

Many people believe lots of clinical trials of novel therapeutics targeting mechanisms of aging will start up in the next few years

Read more...

Lifespan.io summarises the proceedings of the Buck Institute's Longevity Summit

Lifespan.io (LEAF) - 20-Jan-2023

Another reminder of the amount of research, with multiple approaches, about to go into clinical trials

Read more...

Juvena Therapeutics receives $50M to uncover therapeutic links between secreted proteins and diseases

Biospace - 08-Nov-2022

Its a fully integrated approach for developing biologics for chronic and age-related diseases

Read more...

LEAF interviews Hanadie Yousef, co-founder and CEO of Juvena Therapeutics

Lifespan.io (LEAF) - 11-Feb-2020

Muscle regeneration would have a huge hit on healthspan - getting people more mobile again

Read more...

Forget blood transfusions, the fountain of youth could be closer to hand

Lifespan.io (LEAF) - 18-Jan-2017

Attempts have been made to rejuvenate the body by transfusing old people with young blood. Recen...

Read more...
Topics mentioned on this page:
Stem Cells